Oscar Health, Inc. (NYSE:OSCR) Receives $22.93 Consensus Price Target from Analysts

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eight analysts that are presently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $22.93.

A number of research analysts have issued reports on OSCR shares. UBS Group began coverage on shares of Oscar Health in a research report on Monday, October 7th. They set a "neutral" rating and a $23.00 target price on the stock. Bank of America lowered shares of Oscar Health from a "neutral" rating to an "underperform" rating and cut their price objective for the company from $21.00 to $13.50 in a report on Wednesday, November 6th. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th.

Insider Transactions at Oscar Health

In related news, CAO Victoria Baltrus sold 4,226 shares of the firm's stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now directly owns 140,648 shares in the company, valued at $2,530,257.52. This trade represents a 2.92 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $17.05, for a total transaction of $426,250.00. Following the completion of the sale, the director now directly owns 89,512 shares in the company, valued at $1,526,179.60. This represents a 21.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have acquired 1,055,478 shares of company stock valued at $14,432,852 and have sold 194,569 shares valued at $3,433,319. 25.11% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Price T Rowe Associates Inc. MD boosted its position in Oscar Health by 153.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company's stock worth $59,156,000 after acquiring an additional 2,409,160 shares during the last quarter. Westfield Capital Management Co. LP acquired a new position in Oscar Health during the third quarter worth $27,452,000. First Light Asset Management LLC grew its position in Oscar Health by 117.3% in the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company's stock valued at $31,265,000 after purchasing an additional 1,134,919 shares in the last quarter. Renaissance Technologies LLC increased its stake in Oscar Health by 31.7% in the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company's stock valued at $61,478,000 after buying an additional 934,600 shares during the last quarter. Finally, Point72 Asset Management L.P. bought a new stake in Oscar Health during the 2nd quarter worth about $14,716,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Trading Down 2.0 %

OSCR stock traded down $0.33 during trading on Friday, hitting $15.98. The company had a trading volume of 5,131,339 shares, compared to its average volume of 5,597,619. The stock has a market cap of $3.95 billion, a price-to-earnings ratio of -266.29 and a beta of 1.67. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a 50-day moving average price of $17.90 and a 200-day moving average price of $18.20. Oscar Health has a 12 month low of $7.29 and a 12 month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.20) by ($0.02). The firm had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The company's revenue was up 68.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.29) EPS. As a group, analysts predict that Oscar Health will post -0.01 earnings per share for the current year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.